Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
The Comprehensive Self-Management Intervention has been effective for patients with irritable bowel syndrome, which shares similar symptoms with inflammatory bowel disease. This suggests it might also help people with inflammatory bowel disease manage their symptoms better.
12345The available research does not specifically address safety concerns for the Comprehensive Self-Management Intervention, but it has been used in studies for irritable bowel syndrome and inflammatory bowel disease without reported safety issues.
12456The Comprehensive Self-Management Intervention (CSM-IBD) is unique because it focuses on nonmedical self-management strategies, combining cognitive behavioral therapy (a type of talk therapy) with relaxation and dietary strategies, tailored specifically for people with inflammatory bowel disease. This 8-session program is delivered over 8-12 weeks with support from a registered nurse, aiming to help patients manage symptoms like abdominal pain and fatigue, which are not typically addressed by standard medical treatments.
12356Eligibility Criteria
This trial is for English-speaking individuals with a healthcare provider's diagnosis of inflammatory bowel disease (IBD), including Crohn's Disease and Ulcerative Colitis, who are currently experiencing symptoms. It's not open to those living outside Washington state or anyone who has had bowel-related surgery in the past month.Inclusion Criteria
Exclusion Criteria